Literature DB >> 9175873

A novel model for the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator.

J P Annereau1, U Wulbrand, A Vankeerberghen, H Cuppens, F Bontems, B Tümmler, J J Cassiman, V Stoven.   

Abstract

Cystic fibrosis is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The most frequent mutation is the deletion of F508 in the first nucleotide binding fold (NBF1). It induces a perturbation in the folding of NBF1, which impedes posttranslational maturation of CFTR. Determination of the three-dimensional structure of NBF1 would help to understand this defect. We present a novel model for NBF1 built from the crystal structure of bovine mitochondrial F1-ATPase protein. This model gives a reasonable interpretation of the effect of mutations on the maturation of the protein and, in agreement with the CD data, leads to reconsideration of the limits of NBF1 within CFTR.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9175873     DOI: 10.1016/s0014-5793(97)00363-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Genome analysis: Assigning protein coding regions to three-dimensional structures.

Authors:  A A Salamov; M Suwa; C A Orengo; M B Swindells
Journal:  Protein Sci       Date:  1999-04       Impact factor: 6.725

2.  The first-nucleotide binding domain of the cystic-fibrosis transmembrane conductance regulator is important for inhibition of the epithelial Na+ channel.

Authors:  R Schreiber; A Hopf; M Mall; R Greger; K Kunzelmann
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

3.  DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis.

Authors:  N Kälin; A Claass; M Sommer; E Puchelle; B Tümmler
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

4.  Ligand-driven vectorial folding of ribosome-bound human CFTR NBD1.

Authors:  Amardeep Khushoo; Zhongying Yang; Arthur E Johnson; William R Skach
Journal:  Mol Cell       Date:  2011-03-18       Impact factor: 17.970

5.  Small-angle X-ray scattering study of the ATP modulation of the structural features of the nucleotide binding domains of the CFTR in solution.

Authors:  Lauretta Galeno; Elena Galfrè; Oscar Moran
Journal:  Eur Biophys J       Date:  2011-03-22       Impact factor: 1.733

6.  Modeling of nucleotide binding domains of ABC transporter proteins based on a F1-ATPase/recA topology: structural model of the nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator (CFTR).

Authors:  M A Bianchet; Y H Ko; L M Amzel; P L Pedersen
Journal:  J Bioenerg Biomembr       Date:  1997-10       Impact factor: 2.945

7.  Chimeric constructs endow the human CFTR Cl- channel with the gating behavior of murine CFTR.

Authors:  Toby S Scott-Ward; Zhiwei Cai; Elizabeth S Dawson; Ann Doherty; Ana Carina Da Paula; Heather Davidson; David J Porteous; Brandon J Wainwright; Margarida D Amaral; David N Sheppard; A Christopher Boyd
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-03       Impact factor: 11.205

8.  Severed molecules functionally define the boundaries of the cystic fibrosis transmembrane conductance regulator's NH(2)-terminal nucleotide binding domain.

Authors:  K W Chan; L Csanády; D Seto-Young; A C Nairn; D C Gadsby
Journal:  J Gen Physiol       Date:  2000-08       Impact factor: 4.086

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.